Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Huntington's disease symptoms
ACTRN12616001611415Phase 2Recruiting
- Sponsor
- The University of Auckland
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Huntington disease (HD) comparing Champix with Placebo (2 arms). Primary endpoints: Functional performance, Cognitive testing task 1: motor tapping and 6 more. Started Nov 2015; status: recruiting.
02
Drugs
varenicline
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on ACTRN12616001611415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001611415.